Medicinova MNOV
NASDAQ MNOV
$1.36 -0.02 (-1.45%)
At close: Aug 20, 2026 · 4:00 PM EDT

Medicinova (MNOV) Total Debt (2010)

Medicinova (MNOV) posted quarterly Total Debt of $14.4 million for Q4 2010.

Medicinova (MNOV) Total Debt (2010) Analysis & Trends

Medicinova (MNOV) has reported Total Debt for 1 consecutive years, with $14.4 million the latest figure, recorded in Q4 2010.

  • In Q4 2010, Total Debt changed N/A year-over-year to $14.4 million; the TTM figure through Dec 2010 stood at $14.4 million (changed N/A YoY), while the FY2010 annual figure was $14.4 million, changed N/A from the prior year.
  • Total Debt steadied at $14.4 million in Q4 2010 per MNOV's latest filing.
  • Across five years, Total Debt topped out at $14.4 million in Q4 2010 and bottomed at $14.4 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.07 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 546.77 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 9.34 Bn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 770.36 Mn
10 Medicinova 66.94 Mn 66.94 Mn 317,759.00 -

Historic Data

Download Data
DateValue
Dec 31, 2010 14.44 Mn